LinkedInFacebookTwitterInstagramYouTubeEmailPhone

OTC Drug Manufacturers are Required to Pay FDA Facility User Fees by May 10, 2021

Co-Authored by Denise Calle.

On March 26, 2021, Food and Drug Administration (FDA) published the Federal Register Notice, “Fee Rates Under the Over-the-Counter Monograph Drug User Fee Program for Fiscal Year 2021,” announcing the OTC Monograph Drug user fee program fee rates for FY 2021. This is the first year FDA has expanded user fees to OTC Drug Manufacturers and submitters of OTC monograph order requests.

[…]

By |2021-04-26T10:08:08-04:00April 8, 2021|Best Practices, Customs Expert, Enforcement, Export, International Business, International Law, International Trade, Pre-compliance, U.S. Food and Drug Administration (FDA)|Comments Off on OTC Drug Manufacturers are Required to Pay FDA Facility User Fees by May 10, 2021
Read More

FDA Webinar on Human Drug Importations

On January 14, 2021, the United States Food and Drug Administration (FDA)  kicked off the year with a set of Webinars for the trade community. Specifically, the Center for Drug Evaluation and Research (CDER) held its first annual Small Business and Industry Assistance (SIBA) Compliance Conference.  The topics covered various areas dedicated to compliance including compounding in cleanrooms, drug importation requirements, drug supply chain security act implementation, and Risk Evaluation and Mitigation Strategies (REMS) compliance.

[…]

By |2022-07-07T12:33:06-04:00March 2, 2021|Best Practices, Customs Expert, Enforcement, Events, Export, Import, International Business, International Law, International Trade, Supply Chain, U.S. Customs and Border Protection (CBP), U.S. Food and Drug Administration (FDA)|Comments Off on FDA Webinar on Human Drug Importations
Read More
Go to Top